Stocks in play: XORTX Therapeutics Inc.
Announces that it has received TSX Venture Exchange approval to amend the terms of the balance of outstanding ...
Stocks in play: XORTX Therapeutics Inc
Announced the grant of Orphan Drug Designation for oxypurinol – “orphan-drug designation request of ...
XORTX Announces Submission to European Medicines Agency
Scientific Advice from EMA Committee for Medicinal Products for Human Use Requested...
XORTX Announces Positive Topline Results from Pharmacokinetics Bridging Clinical Trial
Clinical Trial Shows Substantially Improved Bioavailiability...
XORTX Announces Pre-Phase 3 Meeting Request with US Food and Drug Administration (FDA)
CALGARY, Alberta, July 07, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a...
XORTX to Present at BIO International Convention 2022
CALGARY, Alberta, June 13, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a...